Cowen Inc’s Alaunos Therapeutics TCRT Stock Holding History

Cowen Inc’s Portfolio TCRT Stock Details TCRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-89	Closed	-$54K	–	325
2014 Q2	$54K	Buy	+89	New	+$49.6K	0.01%	238

Other funds holding TCRT

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Cowen Inc's TCRT Position: Q3 2014 in Review

Cowen Inc sold out of Alaunos Therapeutics (TCRT) in Q3 2014, closing a stake of 89 shares — an estimated $54K sold.

Cowen Inc first reported a position in TCRT in Q2 2014 and held it in 1 quarter. The position peaked at $54K in Q2 2014. 94 funds tracked by Wall St. Rank hold TCRT as of Q3 2014.

Cowen Inc reported no remaining Alaunos Therapeutics position as of Q3 2014 after selling out during the quarter.
Cowen Inc sold 89 Alaunos Therapeutics shares in Q3 2014, an estimated $54K.
Cowen Inc first reported a position in Alaunos Therapeutics in Q2 2014 and held it in 1 quarter.
Cowen Inc's Alaunos Therapeutics position peaked at $54K in Q2 2014.
94 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2014.

Based on Cowen Inc's 13F filing for Q3 2014, filed 17 Nov 2014.